Fineline Cube

Follow:
14483 Articles
CompanyDeals

Neuro3 Therapeutics Secures Exclusive License Deal with Lundbeck for KCNQ2 Activator Programs

Company

Organon Reports Q1 2023 Revenue Growth, Highlights Women’s Health and Biosimilars Progress

CompanyDrug

US FDA Nears Regulatory Decision on Junshi Biosciences’ PD-1 Inhibitor Tuoyi

CompanyDeals

Acorda Therapeutics Strikes Deal with Hangzhou Chance for Inbrija Distribution in China

CompanyDrug

RemeGen Ltd Receives Approval for Phase I Clinical Study of RC198 in Solid Tumors

CompanyDrug

Grand Pharmaceutical Group Completes Enrollment in Phase III Study for Ryaltris Nasal Spray

CompanyDrug

Alphamab Oncology and CSPC Pharma Get Green Light for KN026 Phase III Study in Breast Cancer

CompanyDrug

Eyenovia, Inc. Receives FDA Approval for Mydcombi, a First-of-Its-Kind Ophthalmic Spray

DrugPolicy / Regulatory

NMPA Releases 67th Batch of Reference Drugs for Generic Quality Consistency Evaluation

CompanyDrug

Jiangsu Hengrui Pharmaceuticals Advances SHR-1819, SHR-2002, and Adebrelimab into New Clinical Trials

CompanyDrug

Ascletis Pharma Receives Approval for Phase IIa Study of ASC10 for RSV Infection

CompanyDeals

EQRx Inc. Abandons Plans for Low-Cost Drugs, Terminates Development of Three China-Sourced Products